Abstract:Previous research suggests that the neuropeptide orexin A contributes to sympathetic blood pressure (BP) control inasmuch as hypothalamic injection of orexin A increases sympathetic vasomotor tone and arterial BP in rodents. In humans with narcolepsy, a disorder associated with loss of orexin-producing neurons, vasoconstrictive muscle sympathetic nerve activity (MSNA) is reduced. Since intranasally administered oligopeptides like orexin are known to modulate brain function, we investigated the effect of intranasal orexin A on vascular sympathetic baroreflex function in healthy humans. In a balanced, double-blind crossover study, orexin A (500 nmol) and placebo, respectively, were intranasally administered to 10 lean healthy males (age 25.8 ± 4.6 yr). MSNA was assessed microneurographically before and 30-45 min after either substance administration. Additionally, baroreflex was challenged via graded infusions of vasoactive drugs before and after substance administration. Baroreflex function was defined as the correlation of BP with MSNA and heart rate. Intranasal orexin A compared with placebo induced a significant increase in resting MSNA from pre-to postadministration [Δburst rate, orexin A vs. placebo: +5.8 ± 0.8 vs. +2.1 ± 0.6 bursts/min, P = 0.007; total activity 169 ± 11.5% vs. 115 ± 5.0%; P = 0.002]. BP, heart rate, and sympathovagal balance to the heart, as represented by heart rate variability (HRV), as well as baroreflex sensitivity during the vasoactive challenge were not altered. Intranasally administered orexin A acutely induced vasoconstrictory sympathoactivation in healthy male humans. This result suggests that orexin A mediates upward resetting of the vascular baroreflex set point at centers superordinate to the mere baroreflex feedback loop.NEW & NOTEWORTHY Our pilot study adds another important part to the complex network of neuroendocrine-sympathetic interaction. Our results demonstrate that intranasal orexin A elicits an excitatory effect on sympathetic vascular tone superordinate to mere baroreflex feedback regulation. This resetting of the baroreflex set point suggests an activation of hypothalamic core centers such as the paraventricular nucleus (PVN). The role of the orexinergic system in the development of neurogenic arterial hypertension warrants further investigations.

Orexin A Increases Sympathetic Nerve Activity Through Promoting Expression of Proinflammatory Cytokines in Sprague Dawley Rats

Central Actions of Orexin-a on Hypothalamic Paraventricular Nucleus Activity in Conscious, Freely Moving Rats

Central action of orexin-A on the neural activity of hypothalamic paraventricular nucleus neuron

Central Hypertonic Nacl Increases Cytokine Expression in the Hypothalamic Paraventricular Nucleus

Microglial‐neuronal Interactions in the Paraventricular Nucleus (PVN): a Potential Mechanism Underlying Neurogenic Hypertension

[Central Action of Orexins on Sympathetic Outflow and Cardiovascular Function with a Focus on the Paraventricular Nucleus of the Hypothalamus].

High Salt Challenge Augments Expression of Proinflammatory Cytokines and Contributes to Elevated Neuronal Activity in the Hypothalamic Paraventricular Nucleus

Orexin-A Excites Airway Vagal Preganglionic Neurons Via Activation of Orexin Receptor Type 1 and Type 2 in Rats

Orexin A regulates cardiovascular responses in stress-induced hypertensive rats.

Increased Activity of the Orexin System in the Paraventricular Nucleus Contributes to Salt-Sensitive Hypertension

Orexin A induced increases in rat locus coeruleus neuronal activity are attenuated by systemic administration of OX1R and OX2R antagonists

Intranasal orexin A modulates sympathetic vascular tone: a pilot study in healthy male humans

Relationship between the elevated orexin sensitivity via OX2R in RVLM and an increased arterial pressure in rats fed a high fat diet

Inflammatory Cytokines in Paraventricular Nucleus Modulate Sympathetic Activity and Cardiac Sympathetic Afferent Reflex in Rats

Orexin Affects Dorsal Root Ganglion Neurons: a Mechanism for Regulating the Spinal Nociceptive Processing.

Implicación de los canales L de Ca2+ en el efecto de la orexina A sobre la entrada de Ca2+ extracelular en neuronas de la corteza prefrontal de rata

Orexin-A directly depolarizes dorsomedial hypothalamic neurons, including those innervating the rostral ventrolateral medulla

The Effect of Orexin-A on Cardiac Dysfunction Mediated by NADPH Oxidase-Derived Superoxide Anion in Ventrolateral Medulla

Activation of orexin 1 receptors in the periaqueductal gray of male rats leads to antinociception via retrograde endocannabinoid (2-arachidonoylglycerol)-induced disinhibition

Orexin Facilitates the Peripheral Chemoreflex via Corticotropin-Releasing Hormone Neurons Projecting to the Nucleus of the Solitary Tract

Orexin-A differentially modulates inhibitory and excitatory synaptic transmission in rat inner retina